Renewsha highlights consistent dosing with its dissolvable CBD tablets
As it gains traction in the company’s home state, Renewsha is highlighting the consistency that its flagship product offers. The Hanover, Mich.-based company markets Renewsha orally dissolving CBD tablets, which use a patent-pending formula to deliver 30 mg of CBD in each dose.
“Renewsha represents a whole new way to take CBD and experience its unique benefits,” said Nic Hohne, who works with Renewsha's distribution partner. “Instead of guessing how much oil is in a dropper or where an edible came from with a nasty aftertaste that burns, Renewsha makes CBD consumption safer and more enjoyable while producing faster results.”
The company noted that it uses a third-part lab testing facility regulated by Michigan to verify the quality of every batch formula. It noted that its hemp extact CBD is free of THC.
